The Dresden centre will begin its work with comprehensive basic research in the field of cellular and developmental biology, including stem cell research. In the longer term, it is planned to build on this to develop new therapeutic approaches. Stem cell therapy is viewed as having great potential for the treatment of many diseases since it enables controlled tissue regeneration. The cellular mechanisms that control the activity of these stem cells remain largely unknown, however. This is the problem that the centre, which will involve researchers from the life sciences, natural sciences and engineering sciences, aims to address first. One particularly promising project will use model organisms to study the ability for tissue regeneration, extrapolating this information to predict the potential for clinical applications. The long-term goal of the Dresden initiative is to develop approaches for treating metabolic diseases, cancer and immunodeficiencies; diabetes; brain and spinal injuries; for bone and cartilage replacement; and for the treatment of cardiovascular disease.
Researchers from the Dresden University of Technology, the Max Planck Institute of Molecular Cell Biology and Genetics, the Fraunhofer Institute for Ceramic Technologies and Sintered Materials, the Leibniz Institute of Polymer Research and the Rossendorf Research Centre will participate in the centre.
The Dresden proposal was selected from ten applications on the topic of "Regenerative Therapy", three of which made the shortlist. The proposals were reviewed and compared by an international review panel.
DFG Research Centres are an important stra
'"/>
Contact: Dr. Jutta Rateike
jutta.rateike@dfg.de
49-228-885-2665
Deutsche Forschungsgemeinschaft
7-Sep-2005